Correlation Between KDA and VentriPoint Diagnostics

Can any of the company-specific risk be diversified away by investing in both KDA and VentriPoint Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KDA and VentriPoint Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between KDA Group and VentriPoint Diagnostics, you can compare the effects of market volatilities on KDA and VentriPoint Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KDA with a short position of VentriPoint Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of KDA and VentriPoint Diagnostics.

Diversification Opportunities for KDA and VentriPoint Diagnostics

0.07

Correlation Coefficient

KDA  VentriPoint Diagnostics

Significant diversification

The 3 months correlation between KDA and VentriPoint is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding KDA Group and VentriPoint Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VentriPoint Diagnostics and KDA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KDA Group are associated (or correlated) with VentriPoint Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VentriPoint Diagnostics has no effect on the direction of KDA i.e., KDA and VentriPoint Diagnostics go up and down completely randomly.

Pair Corralation between KDA and VentriPoint Diagnostics

Assuming the 90 days horizon KDA Group is expected to generate 0.93 times more return on investment than VentriPoint Diagnostics. However, KDA Group is 1.08 times less risky than VentriPoint Diagnostics. It trades about 0.03 of its potential returns per unit of risk. VentriPoint Diagnostics is currently generating about -0.1 per unit of risk. If you would invest  28.00  in KDA Group on September 26, 2024 and sell it today you would earn a total of  0.00  from holding KDA Group or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

KDA Group  vs.  VentriPoint Diagnostics

KDA Group

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in KDA Group are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, KDA may actually be approaching a critical reversion point that can send shares even higher in January 2025.

VentriPoint Diagnostics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days VentriPoint Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with KDA and VentriPoint Diagnostics

The main advantage of trading using opposite KDA and VentriPoint Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KDA position performs unexpectedly, VentriPoint Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VentriPoint Diagnostics will offset losses from the drop in VentriPoint Diagnostics' long position.

The idea behind KDA Group and VentriPoint Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.